ORIGINAL PAPER
The role of the rs1421085 polymorphism in the pathogenesis of obesity
1
Department of Rehabilitation, Hollycross Cancer Centre, Kielce, Poland
2
Collegium Medicum, Jan Kochanowski University, Kielce, Poland
3
Department of Epidemiology and Cancer Control, Hollycross Cancer Centre, Kielce, Poland
4
Research and Education Department, Hollycross Cancer Centre, Kielce, Poland
5
Department of Molecular Diagnostic, Hollycross Cancer Centre, Kielce, Poland
6
Clinical Oncology Clinic, Hollycross Cancer Centre, Kielce, Poland
Submission date: 2020-01-11
Final revision date: 2020-05-15
Acceptance date: 2020-06-12
Publication date: 2020-06-30
Medical Studies 2020;36(2):110-115
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Genome-wide association study (GWAS) has revealed the relationship between polymorphisms in the FTO gene and the risk of obesity. Based on the literature data, the authors selected the rs1421085 polymorphism of the FTO gene associated with an increased risk of obesity. Data on the Polish population are scarce.
Aim of the research:
Analysis of the relationship between the rs1421085 FTO gene polymorphism and the risk of obesity among participants of the PONS study (Polish Norwegian Study).
Material and methods:
The verification covered data from 200 Polish residents who participated in the PONS study. Peripheral blood lymphocyte DNA was isolated from the available blood samples using the Genomic Micro AX Blood Gravity Kit (A&A Biotechnology). The quality and quantity of DNA obtained were checked using a NanoDrop One/OneC (Thermo Scientific) spectrophotometer. A commercial set of primers and probes and the TaqManTM Genotyping Master Mix (Thermo Scientific) using the QuantStudio 5 Real-Time PCR System device (Thermo Scientific) according to the manufacturer’s protocol were used for genotyping the rs1421085 FTO gene.
Results:
People with obesity had statistically significantly higher systolic blood pressure (p < 0.001), higher triglyceride concentration (p < 0.001), and lower total cholesterol (p < 0.01). In the serum of obese people statistically significantly higher glucose levels were found compared to the control group (p < 0.001). The genotype distribution for the rs1421085 FTO gene polymorphism in the entire study group was 29.5% for TT homozygotes, 45% for CT heterozygotes, 25.5% for CC homozygotes.
Conclusions:
The rs1421085 polymorphism of the FTO gene does not show a statistically significant association with the occurrence of obesity in the Polish population. The lack of association between the rs1421085 polymorphism of the FTO gene and obesity may result from the small size of the examined group. Analyses of a larger group of respondents are necessary.
Genome-wide association study (GWAS) has revealed the relationship between polymorphisms in the FTO gene and the risk of obesity. Based on the literature data, the authors selected the rs1421085 polymorphism of the FTO gene associated with an increased risk of obesity. Data on the Polish population are scarce.
Aim of the research:
Analysis of the relationship between the rs1421085 FTO gene polymorphism and the risk of obesity among participants of the PONS study (Polish Norwegian Study).
Material and methods:
The verification covered data from 200 Polish residents who participated in the PONS study. Peripheral blood lymphocyte DNA was isolated from the available blood samples using the Genomic Micro AX Blood Gravity Kit (A&A Biotechnology). The quality and quantity of DNA obtained were checked using a NanoDrop One/OneC (Thermo Scientific) spectrophotometer. A commercial set of primers and probes and the TaqManTM Genotyping Master Mix (Thermo Scientific) using the QuantStudio 5 Real-Time PCR System device (Thermo Scientific) according to the manufacturer’s protocol were used for genotyping the rs1421085 FTO gene.
Results:
People with obesity had statistically significantly higher systolic blood pressure (p < 0.001), higher triglyceride concentration (p < 0.001), and lower total cholesterol (p < 0.01). In the serum of obese people statistically significantly higher glucose levels were found compared to the control group (p < 0.001). The genotype distribution for the rs1421085 FTO gene polymorphism in the entire study group was 29.5% for TT homozygotes, 45% for CT heterozygotes, 25.5% for CC homozygotes.
Conclusions:
The rs1421085 polymorphism of the FTO gene does not show a statistically significant association with the occurrence of obesity in the Polish population. The lack of association between the rs1421085 polymorphism of the FTO gene and obesity may result from the small size of the examined group. Analyses of a larger group of respondents are necessary.
REFERENCES (23)
1.
Krekora-Wollny K, Suliga E. Changes in body mass during weight loss treatment – a two-year prospective study. Med Stud 2017; 33: 290-294.
2.
Majda A, Zalewska-Puchała J, Kamińska A, Bodys-Cupak I, Suder M. Risk factors for diseases of the cardiovascular system among Catholics living in areas of southern Poland. Med Stud 2017; 33: 88-94.
3.
Zara-Lopes T, Galbiatti-Dias LSA, Urbanin Castanhole-Nunes MM, Padovani-Júnior JA, Maniglia JV, Pavarino EC, Goloni-Bertollo EM. Polymorphisms in MTHFR, MTR, RFC1 and CbetaS genes involved in folate metabolism and thyroid cancer: a case-control study. Arch Med Sci 2019; 15: 522-530.
4.
Kabała M, Wilczynski J. Otyłość a stabilność posturalna kobiet po mastektomii. Stud Med 2019; 35: 48-54.
5.
Kała E, Bodek I, Trelińska O, Gładysz P, Lepiarczyk O, Śmigel A, Gola M, Grzeszczak W. Polymorphism rs7903146 of TCF7L2 gene and occurrence of being overweight and obesity among patients admitted to outpatient clinic. Ann Acad Med Siles 2014; 68: 200-206.
6.
Frayling TM, Timpson NJ, Weedon MN, Zeggini E, Freathy RM, Lindgren CM, Perry JRB, Elliott KS, Lango H, Rayner NW, Shields B, Harries LW, Barrett JC, Ellard S, Groves CJ, Knight B, Patch AM, Ness AR, Ebrahim S, Lawlor DA, Ring SM, Ben-Shlomo Y, Jarvelin MR, Sovio U, Bennett AJ, Melzer D, Ferrucci L, Loos RJF, Barroso I, Wareham NJ, Karpe F, Owen KR, Cardon LR, Walker M, Hitman GA, Palmer CNA, Doney ASF, Morris AD, Smith GD, The Wellcome Trust Case Control Consortium, Hattersley AT, McCarthy MI. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 2007; 316: 889-894.
7.
Speliotes EK, Willer CJ, Berndt SI, Monda KL, Thorleifsson G, Jackson AU. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet 2010; 42: 937-948.
8.
Larder R, Cheung MKM, Tung YCL, Yeo GSH, Coll AP. Where to go with FTO? Trends Endocrinol Metab 2011; 22: 53-59.
9.
Speakman JR, Rance KA, Johnstone AM. Polymorphisms of the FTO gene are associated with variation in energy intake, but not energy expenditure. Obesity 2008; 16: 1961-1965.
10.
Speakman JR. The “fat mass and obesity related” (FTO) gene: mechanisms of impact on obesity and energy balance. Curr Obes Rep 2015; 4: 73-91.
11.
Ehrlich AC, Friedenberg FK. Genetic associations of obesity: the fat-mass and obesity-associated (FTO) gene citation. Clin Transl Gastroenterol 2016; 7: e140.
12.
Woźny Ł, Wojtas E, Chuchmacz G, Maciejiczek J, Karon M, Kandefer B, Śnit M, Grzeszczak W. The effect of rs1421085 polymorphism of FTO gene on progress of hypertension in overweight and obese subjects. Ann Acad Med Siles 2016; 70: 51-55.
15.
Kolackov K, Łaczmański Ł, Bednarek-Tupikowska G. Influence of FTO gene polymorphisms on the risk of obesity. Endokrynol Otyłość Zaburzenia Przem Materii 2010; 2: 101-107.
16.
Albuquerque D, Nobrega C, Manco L. Association of FTO polymorphisms with obesity and obesity-related outcomes in Portuguese children. PLoS One 2013; 8: e54370.
17.
Kopelman P. Health risks associated with overweight and obesity. Obes Rev 2007; 8 Suppl 1: 13-17.
18.
Cha SW, Choi SM, Kim KS, Park BL, Kim JR, Kim JY, Shin HD. Replication of genetic effects of FTO polymorphisms on BMI in a Korean population. Obesity 2008; 16: 2187-2189.
19.
Dougkas A, Yaqoop P, Givens DI, Reynolds CK, Minihane AM. The impact of obesity-related SNP on appetite and energy intake. Br J Nutr 2013; 110: 1151-1156.
20.
Solak M, Erdogan MO, Yildiz SH, Ucok K, Yuksel S, Terzi E, Bestepe A. Association of obesity with rs1421085 and rs9939609 polymorphisms of FTO gene. Mol Biol Rep 2014; 41: 7381-7386.
21.
Ohashi J, Naka I, Kimura R, Natsuhara K, Yamauchi T, Furusawa T, Nakazawa M, Ataka Y, Patarapotikul J, Nuchnoi P, Tokunaga K, Ishida T, Inaoka T, Matsumura Y, Ohtsuka R. FTO polymorphisms in oceanic populations. J Hum Genet 2007; 52: 1031-1035.
22.
Macek P, Biskup M, Terek-Derszniak M, Stachura M, Krol H, Gozdz S, Zak M. Optimal body fat percentage cut-off values in predicting the obesity-related cardiovascular risk factors – a cross-sectional cohort study. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020; 13: 1587-1597.
23.
Macek P, Zak M, Terek-Derszniak M, Biskup M, Ciepiela P, Krol H, Smok-Kalwat J, Gozdz S. Age-dependent disparities in the prevalence of single and clustering cardiovascular risk factors: a cross-sectional cohort study in middle-aged and older adults. Clin Interv Aging 2020; 15: 161-169.
Share
RELATED ARTICLE
| eISSN: | 2300-6722 |
| ISSN: | 1899-1874 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
